Adrenoceptor agonist poisoning after accidental oral ingestion of brimonidine eye drops

Pediatric Critical Care Medicine

Volumn 5, Issue 3, 2004, Pages 282-285

  Hoffmann, Ullrich ^a   Kuno, Saskia ^b   Franke, Gerd ^a   Fusch, Christoph ^b   Haas, Johannes P ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

2 adrenergic agonist; Brimonidine; Children; Intoxication; Pharmacokinetics

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; EYE DROPS; QUINOXALINE DERIVATIVE;

ARTICLE; CASE REPORT; HUMAN; MALE; METABOLIC CLEARANCE RATE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-AGONISTS; CHILD, PRESCHOOL; HUMANS; MALE; METABOLIC CLEARANCE RATE; OPHTHALMIC SOLUTIONS; QUINOXALINES;

EID: 5144226403     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/01.PCC.0000123548.73664.18     Document Type: Article

References (16)

1. Cantor LB: The evolving pharmacotherapeutic profile of brimonidine, an α2 adrenergic agonist, after four years of continuous use. Exp Opin Pharmacother 2000; 1:815-834
2. Le Blanc RP, Brimonidine Study Group 2: Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% twice daily in patients with glaucoma or ocular hypertension. Ophthalmology 1998; 105:1960-1967
3. Melamed S, David R: Ongoing assessment of the safety profile and efficacy of brimonidine compared with timolol: Year-three results. Clin Ther 2000; 22:103-111
4. Adkins J, Balfour J: Brimonidine. Drugs Aging 1998; 12:225-241
5. Rangnan C, Ingels M, Clark RF: Systemic alpha-2 poisoning with therapeutic use of Alphagan eye drops in an infant. J Toxicol Clin Tox 2000; 38:578
6. Berlin RJ, Lee UT, Samples JR, et al: Ophthalmic drops causing coma in an infant. J Pediatr 2001; 138:441-443
7. Korsch E, Grote A, Seybold M: Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma. Eur J Pediatr 1999; 158:685
8. Carlsen JO, Zabriskie NA, Kwon YH: Apparent central nervous system depression in infants after the use of topical brimonidine. Am J Ophtalmol 1999; 128:255-256
9. Enyedi L, Freedmann S: Safety and efficacy of brimonidine in children with glaucoma. J AAPOS 2001; 5:281-284
10. Acheampong A, Tang-Liu DD-S: Measurement of brimonidine concentrations in human plasma by a highly sensitive gas chromatography/mass spectrometric assay. J Pharm Biomed Anal 1995; 13:995-1002
11. Edlund PO: Determination of clonidine in human plasma by glass capillary gas chromatography with electron-capture detection. J Chromatogr 1980; 187:161-169
12. Sztajnbok J: Failure of naloxone to reverse brimonidine-induced coma in an infant. J Pediatr 2002; 140:484-486
13. Klein-Schwarz W: Trends and toxic effects from pediatric clonidine exposures. Arch Pediatr Adolesc Med 2002; 156:392-396
14. Wedin GP, Richardson SL, Wallace GH: Clonidine poisoning in children. Am J Dis Child 1990; 144:853
15. Bamshad MJ, Wassermann GS: Pediatric clonidine intoxications. Vet Hum Toxicol 1990; 32:220-223
16. Wasserman GS, Mydler TT, Watson WA: Pediatric clonidine levels and toxicity. Vet Hum Toxicol 1992; 34:335